Abstract
Pituitary tumors are highly vascular neoplasms, which suggest an important role of angiogenesis in pituitary tumor growth. We used the human pituitary cell line (HP75) to examine the effects of the growth factors TGFβ1, bFGF, and EGF on cell growth, and on the regulation of the pro-angiogenic growth factor VEGF-A and the VEGFR-I and the anti-angiogenic molecules thrombospondin (TSP) TSP-1 and TSP-2 along with TSP-3. Real-time RT-PCR was used to measure mRNA levels, and Western blot was used to analyze TSP-1 and TSP-2 protein levels.
TGFβ1 treatment (1×10−9 M) increased VEGF-A mRNA levels significantly (p<0.05) after 4 and 24 h of treatment. TGF β1 treatment decreased VEGF-R mRNA levels after 96 h of treatment (p<0.05). After 96 h of treatment, TSP-1 and TSP-2 mRNA levels were significantly increased (p<0.05) by TGFβ1 treatment, which also inhibited HP75 cell growth. Basic FGF also increased TSP-1 mRNA levels after 96 h of treatment, but did not regulate growth of the pituitary tumor cells. Basic FGF and EGF did not modulate changes in VEGF-A mRNA levels after 4 and 24 h of treatment, but EGF increased VEGF-A significantly (p<0.05) after 96 h of treatment.
These results indicate that TGFβ1 treatment may regulate angiogenesis in pituitary cells by initially increasing levels of pro-angiogenic VEGF-A and then stimulating the anti-angiogenic molecules TSP-1 and TSP-2 levels.
Similar content being viewed by others
References
Folkman, J. (1995). Nat. Med. 1, 27–31.
Ferrara, N. and Alitalo, K. (1999). Nat. Med. 5, 1359–1364.
Lloyd, R. V., Vidal, S., Horvath, E., Kovacs, K., and Scheithauer, B. (2003). Microsc. Res. Tech. 60, 244–250.
Hanahan, D. and Folkman, J. (1996). Cell 86, 353–364.
Ferrara, N. (2000). Curr. Opin. Biotechnol. 11, 617–624.
Ferrara, N., Gerber, H. P., and LeCouter, J. (2003). Nat. Med. 9, 669–676.
Iruela-Arispe, M. L. and Sage, E. H. (1993). J. Cell Biochem. 52, 414–430.
Sankar, S., Mahooti-Brooks, N., Bensen, L., McCarthy, T. L., Centrella, M., and Madri, J. A. (1996). J. Clin. Invest. 97, 1436–1446.
Ezzat, S., Zheng, L., Zhu, X. F., Wu, G. E., and Asa, S. L. (2002). J. Clin. Invest. 109, 69–78.
Schechter, J. and Weiner, R. (1991). Endocrinology 129, 2400–2408.
Gospodarowicz, D., Brown, K. D., Birdwell, C. R., and Zetter, B. R. (1978). J. Cell Biol. 77, 774–788.
Gould, J., Aramburo, C., Capdevielle, M., and Scanes, C. G. (1995). Life Sci. 56, 587–594.
de Fraipont, F., Nicholson, A. C., Feige, J. J., and Van Meir, E. G. (2001). Trends Mol. Med. 7, 401–407.
Armstrong, L. C. and Bornstein, P. (2003). Matrix Biol. 22, 63–71.
Rice, A. J., Steward, M. A., and Quinn, C. M. (2002). J. Clin. Pathol. 55, 921–925.
Grossfeld, G. D., Ginsberg, D. A., Stein, J. P., et al. (1997). J. Natl. Cancer Inst. 89, 219–227.
Lloyd, R. V., Scheithauer, B. W., Kuroki, T., Vidal, S., Kovacs, K., and Stefaneanu, L. (1999). Endocr. Pathol. 10, 229–235.
Yamamoto, T., Nishizawa, Y., Tsuji, M., et al. (1999). Endocr. Pathol. 10, 157–164.
Turner, H. E., Nagy, Z., Gatter, K. C., Esiri, M. M., Harris, A. L., and Wass, J. A. (2000). J. Endocrinol. 165, 475–481.
Vidal, S., Kovacs, K., Cohen, S. M., Stefaneanu, L., Lloyd, R. V., and Scheithauer, B. W. (1999). Endocr. Pathol. 10, 109–122.
Vidal, S., Oliveira, M. C., Kovacs, K., Scheithauer, B. W., and Lloyd, R. (2000). Cell Tissue Res. 300, 83–88.
Adolph, K. W. (1999). Biochem. Biophys. Res. Commun. 258, 792–796.
Lahav, J. (1993). Biochim. Biophys. Acta 1182, 1–14.
DiPietro, L. A. (1997). EXS 79, 295–314.
Watnick, R. S., Cheng, Y. N., Rangarajan, A., Ince, T. A., and Weinberg, R. A. (2003). Cancer Cell 3, 219–231.
Kobayashi, I, Jin, L, Ruebel, K. H., Bayliss, J. M., Hidehiro, O, and Lloyd, R. V. (2003). Endocrine 22, 285–292.
Jin, L., Kulig, E., Qian, X., Scheithauer, B. W., Eberhardt, N. L., and Lloyd, R.L. (1998). Endocr. Pathol. 9, 169–184.
Riss, D., Jin, L., Qian, X., et al. (2003). Cancer Res. 63, 2251–2255.
Nicosia, R. F. and Tuszynski, G. P. (1994). J. Cell Biol. 124, 183–193.
Laderoute, K. R., Alarcon, R. M., Brody, M. D., et al. (2000). Clin. Cancer Res. 6, 2941–2950.
de Fraipont, F., El Atifi, M., Gicquel, C., Bertagna, X., Chambaz, E. M., and Feige, J. J. (2000). J. Clin. Endocrinol. Metab. 85, 4734–4741.
Kazuno, M., Tokunaga, T., Oshika, Y., et al. (1999). Eur. J. Cancer 35, 502–506.
Tokunaga, T., Nakamura, M., Oshika, Y., et al. (1999). Br. J. Cancer 79, 354–359.
Murphy-Ullrich, J. E. and Poczatek, M. (2000). Cytokine Growth Factor Rev. 11, 59–69.
Souchelnitskiy, S., Chambaz, E. M., and Feige, J. J. (1995). Endocrinology 136, 5118–5126.
Yehualaeshet, T., O’Connor, R., Green-Johnson, J., et al. (1999). Am. J. Pathol. 155, 841–851.
Folkman, J. and D’Amore, P. A. (1996). Cell 87, 1153–1155.
Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. (1989). Science 246, 1306–1309.
Shibuya, M., Yamaguchi, S., Yamane, A., et al. (1990). Oncogene 5, 519–524.
Lawler, J. and Hynes, R. O. (1986). J. Cell Biol. 103, 1635–1648.
Carron, J. A., Hiscott, P., Hagan, S., Sheridan, C. M., Magee, R., and Gallagher, J. A. (2000). Int. J. Biochem. Cell Biol. 32, 1137–1142.
Adolph, K. W., Long, G. L., Winfield, S., Ginns, E. I., and Bornstein, P. (1995). Genomics 27, 329–336.
Jin, L., Kulig, E., Qian, X., et al. (1999). Pituitary 1, 187–95.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Horiguchi, H., Jin, L., Ruebel, K.H. et al. Regulation of VEGF-A, VEGFR-I, thrombospondin-1, -2, and -3 expression in a human pituitary cell line (HP75) by TGFβ1, bFGF, and EGF. Endocr 24, 141–146 (2004). https://doi.org/10.1385/ENDO:24:2:141
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:24:2:141